As of Jul 31
| +0.03 / +2.17%|
The 2 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 1.00. The median estimate represents a +41.84% increase from the last price of 1.41.
The current consensus among 2 polled investment analysts is to Hold stock in Aveo Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.